Advanced Technology Radiation Therapy Clinical Trials Support (ATC) (Limited Competition U24)
The summary for the Advanced Technology Radiation Therapy Clinical Trials Support (ATC) (Limited Competition U24) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Advanced Technology Radiation Therapy Clinical Trials Support (ATC) (Limited Competition U24): The overall purpose of this Funding Opportunity Announcement (FOA) is to facilitate and support clinical trials that employ advanced technology radiotherapy methods, particularly those requiring digital data submission. To further this goal, the National Cancer Institute (NCI) intends to continue funding for the Advanced Technology Radiation Therapy Clinical Trials Support (ATC) consortium, which was created as a result of RFA-CA-98-006 and continued under RFA-CA-02-505.
Federal Grant Title: | Advanced Technology Radiation Therapy Clinical Trials Support (ATC) (Limited Competition U24) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-CA-07-503 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.395 |
CFDA Descriptions: | Cancer Treatment Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Dec 01, 2006 |
Posted Date: | Oct 16, 2006 |
Creation Date: | Oct 17, 2006 |
Archive Date: | Dec 31, 2006 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible institutions will be restricted to current ATC awardees due to the necessity to preserve and extend the existing infrastructure.The initial 8-year award period has seen the development of an infrastructure which could not be transferred to a different awardee without significant loss of resources and interruption of support for existing and proposed clinical trials protocols. These resources include hardware, software, staff and processes.While the NCI recognizes and endorses the need for full and open competition and, by preference, utilizes open competition for most initiatives, this instance is an exception. It is clear to the Institute that the transfer of the high technology quality assurance program to a new awardee would hamper the ongoing efforts of several of the clinical trials groups as they attempt to utilize more aggressive, high-technology radiation methods in single and combined modality trials.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical...
- • Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial ...
- • Assay development and screening for discovery of chemical probes, drugs or immunomodulator...
- • Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
- • The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clini...
- • Breast and Prostate Cancer Data Quality and Patterns of Care Study
- • Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
- • National Cooperative Drug Discovery Groups for Cancer
- More Grants from the National Institutes of Health
- • Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...